市場調査レポート

商品コード

1303811

血液スクリーニング市場：製品・サービス別（装置、アウトライト購入、試薬・キット）、技術別（ELISA、NAT、NGS）、エンドユーザー別-2023-2030年の世界予測

Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

血液スクリーニングの世界市場は、2023年にCAGR 8.67%で49億897万米ドルと予測され、2030年には驚異的な88億2,691万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の血液スクリーニング市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.血液スクリーニングの世界市場規模および予測は？

2.予測期間中、世界の血液スクリーニング市場を形成するCOVID-19の阻害要因と影響は？

3.血液スクリーニングの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.血液スクリーニングの世界市場における競争戦略は？

5.血液スクリーニングの世界市場における技術動向と規制の枠組みは？

6.血液スクリーニングの世界市場における主要ベンダーの市場シェアは？

7.血液スクリーニングの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 献血需要の高まりと献血数の増加
  - 感染症の蔓延と新たな病原体の出現
  - 血液スクリーニングの手頃な価格と核酸検査の採用の増加
- 抑制要因
  - 血液スクリーニングに関する法律、規制、政策の欠如
- 機会
  - 血液スクリーニングデバイスの技術の進歩
  - 血液スクリーニングのPOC診断の改善
- 課題
  - 血液スクリーニング診断の価格が高い
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章血液スクリーニング市場製品&サービス別

機器
購入
試薬とキット
- ELISA試薬およびキット
  - 結合体
  - コントロール
  - 免疫吸着剤
  - サンプル希釈液と洗浄液
  - 基板
- NAT試薬およびキット
  - バッファー、ヌクレオチド、溶液
  - 酵素とポリメラーゼ
  - 標識試薬および検出試薬
  - プローブとプライマー
  - 基準と管理

第7章血液スクリーニング市場：技術別

ELISA法
- 化学発光免疫測定法
- 比色免疫測定法
- 蛍光免疫測定法
NAT法
- リアルタイムポリメラーゼ連鎖反応
- 転写媒介増幅
NGS
迅速検査
ウェスタンブロットアッセイ

第8章血液スクリーニング市場：エンドユーザー別

血液銀行
病院

第9章南北アメリカの血液スクリーニング市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第10章アジア太平洋地域の血液スクリーニング市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第11章欧州・中東・アフリカの血液スクリーニング市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第12章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第13章掲載企業一覧

第14章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. BLOOD SCREENING MARKET RESEARCH PROCESS
FIGURE 2. BLOOD SCREENING MARKET SIZE, 2022 VS 2030
FIGURE 3. BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
FIGURE 5. BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 6. BLOOD SCREENING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 7. BLOOD SCREENING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. BLOOD SCREENING MARKET DYNAMICS
FIGURE 9. BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. BLOOD SCREENING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 5. BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 8. BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 10. BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 17. BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 25. BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 30. BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 65. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 66. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 67. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 68. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 70. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 71. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 107. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 108. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 109. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 110. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 112. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 113. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 115. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 116. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 117. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 118. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 120. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 121. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 131. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 132. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 133. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 134. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 136. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 137. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 179. THAILAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 180. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 181. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 182. THAILAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 184. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 185. THAILAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. DENMARK BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 205. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 208. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 209. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 210. DENMARK BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. EGYPT BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 212. EGYPT BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 213. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 214. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 215. EGYPT BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. FINLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 220. FINLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 221. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 223. FINLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 225. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 226. FINLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. FRANCE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 228. FRANCE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 229. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 231. FRANCE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 233. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 234. FRANCE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. GERMANY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 236. GERMANY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 237. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 238. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 239. GERMANY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 241. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 242. GERMANY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. ITALY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 252. ITALY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 253. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 254. ITALY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 255. ITALY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 257. ITALY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 258. ITALY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. NORWAY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 276. NORWAY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 277. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 278. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 279. NORWAY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 280. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 281. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 282. NORWAY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 283. POLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 284. POLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 285. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 286. POLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 287. POLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 289. POLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 290. POLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. QATAR BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 292. QATAR BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 293. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 294. QATAR BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 295. QATAR BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 297. QATAR BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 298. QATAR BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. SPAIN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 324. SPAIN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 325. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 326. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 327. SPAIN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 328. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 329. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 330. SPAIN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 331. SWEDEN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 339. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 347. TURKEY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 348. TURKEY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 349. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 350. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 351. TURKEY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 352. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 353. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 354. TURKEY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 363. UNITED

Product Code: MRR-374DB5A06C00

The Global Blood Screening Market is forecasted to grow significantly, with a projected USD 4,908.97 million in 2023 at a CAGR of 8.67% and expected to reach a staggering USD 8,826.91 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Blood Screening Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Blood Screening Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product & Service, market is studied across Instruments, Outright Purchase, and Reagents & Kits. The Reagents & Kits is further studied across ELISA Reagents & Kits and NAT Reagents & Kits. The ELISA Reagents & Kits is further studied across Conjugates, Controls, Immunosorbents, Sample Diluents & Wash Solutions, and Substrates. The NAT Reagents & Kits is further studied across Buffers, Nucleotides, & Solutions, Enzymes & Polymerases, Labeling & Detection Reagents, Probes & Primers, and Standards & Controls. The Instruments is projected to witness significant market share during forecast period.

Based on Technology, market is studied across ELISA, NAT, NGS, Rapid Tests, and Western Blot Assays. The ELISA is further studied across Chemiluminescent Immunoassay, Colorimetric Immunoassay, and Fluorescent immunoassay. The NAT is further studied across Real-Time Polymerase Chain Reaction and Transcription-Mediated Amplification. The NAT is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Blood Banks and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Blood Screening Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Blood Screening Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Blood Screening Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Blood Screening Market?

4. What is the competitive strategic window for opportunities in the Global Blood Screening Market?

5. What are the technology trends and regulatory frameworks in the Global Blood Screening Market?

6. What is the market share of the leading vendors in the Global Blood Screening Market?

7. What modes and strategic moves are considered suitable for entering the Global Blood Screening Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Blood Screening Market, by Product & Service, 2022 vs 2030
4.3. Blood Screening Market, by Technology, 2022 vs 2030
4.4. Blood Screening Market, by End-User, 2022 vs 2030
4.5. Blood Screening Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing demand for donated blood and rising number of blood donations
  - 5.1.1.2. Rising prevalence of infectious diseases and the emergence of newer pathogens
  - 5.1.1.3. Increase in affordability and adoption of nucleic acid test for blood screening
- 5.1.2. Restraints
  - 5.1.2.1. Lack of Legislation, Regulations, and Policies on blood screening
- 5.1.3. Opportunities
  - 5.1.3.1. Technological Advancements in blood screening devices
  - 5.1.3.2. Improved POC diagnostics for blood screening
- 5.1.4. Challenges
  - 5.1.4.1. High price for blood screening diagnostics
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Blood Screening Market, by Product & Service

6.1. Introduction
6.2. Instruments
6.3. Outright Purchase
6.4. Reagents & Kits
- 6.4.1. ELISA Reagents & Kits
  - 6.4.1.1. Conjugates
  - 6.4.1.2. Controls
  - 6.4.1.3. Immunosorbents
  - 6.4.1.4. Sample Diluents & Wash Solutions
  - 6.4.1.5. Substrates
- 6.4.2. NAT Reagents & Kits
  - 6.4.2.1. Buffers, Nucleotides, & Solutions
  - 6.4.2.2. Enzymes & Polymerases
  - 6.4.2.3. Labeling & Detection Reagents
  - 6.4.2.4. Probes & Primers
  - 6.4.2.5. Standards & Controls

7. Blood Screening Market, by Technology

7.1. Introduction
7.2. ELISA
- 7.2.1. Chemiluminescent Immunoassay
- 7.2.2. Colorimetric Immunoassay
- 7.2.3. Fluorescent immunoassay
7.3. NAT
- 7.3.1. Real-Time Polymerase Chain Reaction
- 7.3.2. Transcription-Mediated Amplification
7.4. NGS
7.5. Rapid Tests
7.6. Western Blot Assays

8. Blood Screening Market, by End-User

8.1. Introduction
8.2. Blood Banks
8.3. Hospitals

9. Americas Blood Screening Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Blood Screening Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Blood Screening Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

血液スクリーニング市場：製品・サービス別（装置、アウトライト購入、試薬・キット）、技術別（ELISA、NAT、NGS）、エンドユーザー別-2023-2030年の世界予測

Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 血液スクリーニング市場製品&サービス別

第7章 血液スクリーニング市場：技術別

第8章 血液スクリーニング市場：エンドユーザー別

第9章 南北アメリカの血液スクリーニング市場

第10章 アジア太平洋地域の血液スクリーニング市場

第11章 欧州・中東・アフリカの血液スクリーニング市場

第12章 競合情勢

第13章 掲載企業一覧

第14章 付録